Characterization of <i>Pseudomonas</i> sp. NIBR-H-19, an Antimicrobial Secondary Metabolite Producer Isolated from the Gut of Korean Native Sea Roach, <i>Ligia exotica</i>-Reference-Cited by-同舟云学术

Characterization of Pseudomonas sp. NIBR-H-19, an Antimicrobial Secondary Metabolite Producer Isolated from the Gut of Korean Native Sea Roach, Ligia exotica

Published:2022-10-21 Issue:11 Volume:32 Page:1416-1426
ISSN:1017-7825
Container-title:Journal of Microbiology and Biotechnology
language:en
Short-container-title:J. Microbiol. Biotechnol.

Author:

Hwang Sungmin¹,Yang Jun Hyeok²³,Sim Ho Seok²,Choi Sung Ho⁴,Lee Byounghee⁴,Bang Woo Young⁴,Moon Ki Hwan²³

Affiliation:

1. Clean Energy Research Center, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea

2. Laboratory of Marine Microbiology, Division of Convergence on Marine Science, Korea Maritime and Ocean University, Busan 49112, Republic of Korea

3. Department of Marine Bioscience and Environment, Korea Maritime & Ocean University, Busan 49112, Republic of Korea

4. National Institute of Biological Resources, Environmental Research Complex, Incheon 22689, Republic of Korea

Funder

National Institute of Biological Resources

Ministry of Environment

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Publisher

Korean Society for Microbiology and Biotechnology

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology

Link

http://pdf.medrang.co.kr/JMB2/2022/032/jmb-32-11-1416.pdf

Reference55 articles.

1. Ventola CL. 2015. The antibiotic resistance crisis: part 1: causes and threats. Pharm. Ther. 40: 277.

2. Mechanisms of Antibiotic Resistance

3. The antimicrobial potential of Streptomyces from insect microbiomes

4. Solomon SL, Oliver KB. 2014. Antibiotic resistance threats in the United States: stepping back from the brink. Am. Family Phys. 89: 938-941.

5. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics